Official Malaysian Government Website
Newsroom
868 items
Announcements, product safety communications and regulatory updates.
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
Announcement Latihan Sangkutan di NPRA bagi Latihan Liberalisasi Ahli Farmasi Provisional (PRP) di bawah Bahagian Lembaga Farmasi Malaysia (BLFM): Industri Farmaseutikal Mengilang / Industri…
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
Document attached
Document attached
Bengkel Pengujian Kawalan Kualiti Bahan Mentah Herba Bagi Produk Semulajadi Tarikh: 4 September 2025 Masa: 8.00am - 5.00pm Tempat: Auditorium 2, Blok D1 A, Institut Kesihatan Negara / National…
Document attached
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
Document attached
The National Pharmaceutical Regulatory Agency (NPRA) continues to monitor registered products and notified cosmetics in the local market to ensure the compliance of regulatory requirements in terms…
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
As of April 2025, all RiMUPs for evaluation by the Pharmacovigilance Section, Centre of Compliance & Quality Control (PKKK) [previously requiring manual submission] should be submitted through the…
To enhance the submission process, a dedicated Screening Package for New Drug Products and Biologics has been developed to provide clearer guidance and promote Good Submission Practice. This tool is…
Document attached
DISCLAIMER: This publication is intended for healthcare professionals. The information provided aims to update on medication safety issues and should not substitute clinical judgment. While…
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgment. While reasonable…
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
Document Name Download Updated Guidance Document: Verification for Traditional Medicines (TM) & Health Supplements (HS) Manufacturers, Second Edition, May 2025 DOWNLOAD May - 2025
Document attached
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
Document attached
Document attached
Pekeliling Tarikh Senarai Produk Tidak Berdaftar/Berdaftar Tetapi Tidak Dipasarkan Dengan Bilangan Permohonan Ubat Kelulusan Khas (UKK) Tertinggi Bagi Tahun 2024 2 Mei 2025
Document attached
Overview of Products Azithromycin is a macrolide antibiotic commonly used for treating bacterial infections.1,2 The oral formulation may be used to treat respiratory, skin, ear, and sexually…
Document Name Download Updated Outcome of GVP Inspection Voluntary Phase (2023-2024): Preliminary Key Findings & Trends DOWNLOAD April 2025
Document attached
